These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1266970)

  • 1. Release of prostaglandin F2alpha during splanchnic artery occlusion shock.
    Flynn JT; Bridenbaugh GA; Lefer AM
    Am J Physiol; 1976 Mar; 230(3):684-90. PubMed ID: 1266970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prostaglandin F2alpha and 15-keto-F2alpha concentrations during splanchnic artery occlusion shock.
    Flynn JT; Bridenbaugh GA; Lefer AM
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):193-7. PubMed ID: 1250845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid in splanchnic artery occlusion shock.
    Bridenbaugh GA; Flynn JT; Lefer AM
    Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
    Flynn JT; Lefer AM
    Circ Res; 1977 Apr; 40(4):422-8. PubMed ID: 844155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early prostaglandin release from the ischemic myocardium in the dog.
    Ogletree ML; Flynn JT; Feola M; Lefer AM
    Surg Gynecol Obstet; 1977 May; 144(5):734-40. PubMed ID: 850857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma activation during splanchnic arterial occlusion shock.
    Kistler EB; Lefer AM; Hugli TE; Schmid-Schönbein GW
    Shock; 2000 Jul; 14(1):30-4. PubMed ID: 10909890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock.
    Bitterman H; Aoki N; Lefer AM
    Proc Soc Exp Biol Med; 1988 Jul; 188(3):265-71. PubMed ID: 3393543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A; Rochester JA; Lefer AM
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
    Galvin MJ; Lefer AM
    Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of PGF2 alpha in the superior mesenteric artery-induced shock.
    Mózes T; Wieszt E; Zahajszky T
    J Surg Res; 1989 Dec; 47(6):476-81. PubMed ID: 2586097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG; Braquet P; Mózes T
    Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
    Karasawa A; Guo JP; Ma XL; Lefer AM
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock.
    Johnson G; Lefer AM
    Circ Shock; 1990 Feb; 30(2):155-64. PubMed ID: 2311204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock.
    Bitterman H; Lefer AM
    Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):63-70. PubMed ID: 3406041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of endothelial damage and systemic shock by benidipine, a calcium antagonist, in rats subjected to splanchnic ischemia and reperfusion.
    Karasawa A; Rochester JA; Ma XL; Lefer AM
    Circ Shock; 1991 Mar; 33(3):135-41. PubMed ID: 2044207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock.
    Oei HH; Zoganas HC; Sakane Y; Robson RD; Glenn TM
    Circ Shock; 1986; 18(2):95-106. PubMed ID: 3753907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
    Aoki N; Johnson G; Lefer AM
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.